The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells.

Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14

Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25

The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease. Genome Res (2013) 1.10

Cutting edge: the Y chromosome controls the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL/J mice. J Immunol (2009) 1.03

Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am J Pathol (2004) 0.98

Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology (1989) 0.97

Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am J Pathol (2004) 0.93

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am J Pathol (1999) 0.91

Y genetic variation and phenotypic diversity in health and disease. Biol Sex Differ (2015) 0.84

Peritoneal macrophage from male and female SJL mice differ in IL-10 expression and macrophage maturation. J Leukoc Biol (2012) 0.77

Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection. Proc Natl Acad Sci U S A (2017) 0.77

Increased T regulatory cells lead to development of Th2 immune response in male SJL mice. Autoimmunity (2010) 0.77

Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 6.31

New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45

RNA of mouse hepatitis virus. J Virol (1978) 4.27

Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00

Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81

Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31

A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22

Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06

LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98

High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91

Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86

Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80

Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80

Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46

Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34

Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30

A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol (1999) 2.26

Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21

Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell. J Immunol (1980) 2.19

Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol (1999) 2.19

The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17

Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16

Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12

Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09

Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07

Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07

IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00

Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00

Host cell nuclear function and murine hepatitis virus replication. J Gen Virol (1981) 2.00

Interleukin-1beta promotes repair of the CNS. J Neurosci (2001) 1.92

Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91

Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology (1990) 1.79

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73

Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer. Science (1982) 1.72

Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol (1990) 1.70

Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A (1978) 1.70

Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics (1989) 1.67

Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology (1989) 1.66

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66

Inhibition of immune responses in vitro by specific antiserums to Ia antigens. Science (1975) 1.65

Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol (1998) 1.63

Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62

Tla types of H-2 congenic and recombinant mice. Transplantation (1974) 1.62

Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex. J Exp Med (1976) 1.60

Chronic central nervous system demyelination in mice after JHM virus infection. Neurology (1981) 1.57

Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol (1990) 1.57

Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol (1997) 1.54

Multiple paths for activation of naive CD8+ T cells: CD4-independent help. J Immunol (2001) 1.54

Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology (1987) 1.52

Product of a transferred H-2Ld gene acts as restriction element for LCMV-specific killer T cells. Nature (1982) 1.50

Coronavirus translational regulation: leader affects mRNA efficiency. Virology (1994) 1.50

Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol (1995) 1.46

Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol (1997) 1.45

Coronaviridae. Intervirology (1983) 1.42

Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med (1982) 1.41

Mouse epidermal Ia molecules have a bone marrow origin. Nature (1979) 1.40

Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol Appl Neurobiol (2001) 1.39

T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood (2000) 1.37

Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37

Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36

Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide. J Exp Med (1981) 1.35

In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33

Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33

Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology (1987) 1.32

Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol (2001) 1.31

Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J Virol (2000) 1.31

Monoclonal antibodies reactive with H-2 determinants. Immunogenetics (1983) 1.30

The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology (1998) 1.28

Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect Immun (1988) 1.27

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med (1999) 1.27

T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol (1989) 1.27

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol (2001) 1.26

Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci (2000) 1.26

The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol (1996) 1.24

High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol (2000) 1.24

MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol (2001) 1.23

T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2+ cells. J Exp Med (1978) 1.21

Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J Virol (2000) 1.21

The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains. Immunogenetics (1990) 1.21

Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res (1999) 1.20

RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol (1988) 1.19

Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb Pathog (1987) 1.18

Distribution and characterization of GFP(+) donor hematogenous cells in Twitcher mice after bone marrow transplantation. Am J Pathol (2000) 1.18

In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol (1986) 1.17

Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J Immunol (2000) 1.17

Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc Soc Exp Biol Med (1987) 1.16

Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol (2001) 1.15

A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity (1996) 1.15

Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res (2000) 1.14

Antibody prevents virus reactivation within the central nervous system. J Immunol (1999) 1.14